NCT00406601View on ClinicalTrials.gov

BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

September 30, 2010

Conditions
Sarcoma, Soft Tissue
Interventions
DRUG

Sorafenib (BAY-43-9006)

800 mg/die orally on a continuous basis

Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT00406601 - BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas | Biotech Hunter | Biotech Hunter